Navigation Links
Varian, Inc. Reports First Quarter 2008 Results
Date:1/23/2008

y, plant

and equipment 341 119

Purchase of property, plant

and equipment (3,459) (2,054)

Purchase of businesses, net of

cash acquired (9,987) (3,000)

------------ ------------

Net cash used in investing activities (13,105) (4,935)

------------ ------------

Cash flows from financing activities

Repayments of debt - (1,250)

Repurchase of common stock (15,102) (37,055)

Issuance of common stock 9,518 2,353

Excess tax benefit from share-based plans 2,390 1,173

Transfers to Varian Medical Systems,

Inc. (212) (207)

------------ ------------

Net cash used in financing activities (3,406) (34,986)

------------ ------------

Effects of exchange rate changes on

cash and cash equivalents 692 4,677

------------ ------------

Net increase (decrease) in cash and

cash equivalents 1,284 (12,852)

Cash and cash equivalents at

beginning of period 196,396 154,155

------------ ------------

Cash and cash equivalents at end of period $197,680 $141,303

============ ============

VARIAN, INC. A
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... ,ProtoKinetix Inc. (OTC Bulletin Board: PKTX), a ... commercialization of patented anti-aging,glycopeptides (AAGPs(TM)) announced today ... has received results of tests conducted by ... the biological activity of,AAGP(TM) on the selectin ...
... Consideration, ROCKVILLE, Md., Nov. 10 EntreMed, ... developing,therapeutics for the treatment of cancer and inflammatory ... endpoint for the efficacy portion of,the open label ... pemetrexed,(Alimta(R)) in non-small cell lung cancer patients., ...
... business and product pipeline, BOTHELL, WA and ... OGXI ), a biopharmaceutical company committed,to the ... needs in the treatment of cancer, today reported ... months ended September 30, 2008., Third Quarter ...
Cached Biology Technology:ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 3OncoGenex Reports Third Quarter Financial Results 2OncoGenex Reports Third Quarter Financial Results 3OncoGenex Reports Third Quarter Financial Results 4OncoGenex Reports Third Quarter Financial Results 5OncoGenex Reports Third Quarter Financial Results 6OncoGenex Reports Third Quarter Financial Results 7OncoGenex Reports Third Quarter Financial Results 8OncoGenex Reports Third Quarter Financial Results 9
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a ... it is seeing a staggering demand from its licensees ... the Company revealed, is not solely coming from fitness ... as well. "A wearable is only as ... result, accuracy is the ultimate driver in long-term mass ...
(Date:12/5/2014)... 4, 2014 Increased emphasis on product ... new testing and inspection technologies. The convergence of ... a range of innovative test solutions. This trend ... Y, which is generally more inclined towards communication, ... development strategies of test equipment vendors will cater ...
(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... Robert P. Anderson, Associate Professor of Biology at The City College ... the existence of a new species of spiny pocket mouse, from ... from the Greek katoptrios, which means a "height that commands a ... to its presence on four wet, mountainous forest regions of the ...
... think folks who,ve had knee replacement surgery -- finally able ... instead of put on pounds, but surprisingly that,s not the ... Joseph Zeni and Lynn Snyder-Mackler in the Department of Physical ... typically drop weight in the first few weeks after total ...
... (MS) patients are more often born in spring than in ... factor for the disease. A paper in the journal ... Ellen Mowry, now suggests that this seasonal effect is mediated ... the HLA-DRB1*15 allele of this gene is associated with an ...
Cached Biology News:CCNY biologists identify new spiny pocket mouse species 2Most patients gain weight after getting a new knee, UD study finds 2
... PCR carry-over contamination, which prevents false ... products from previous PCR amplifications without ... improves amplification ,Optimized for use with ... instrument systems , The GeneAmp PCR ...
... that catalyzes the hydrolysis of,starch to ... dextrins. The,level of a-amylase in various ... of,clinical significance in the diagnosis of ... and microbial a-amylases are,important enzymes for ...
... Labsystems Wellmix is a high-quality four-place microplate ... The shaking speed is adjustable from 100 ... speed and a small orbit ensure effective ... time is quick and easy to set ...
Rabbit polyclonal to STUB1 ( Abpromise for all tested applications). entrezGeneID: 10273 SwissProtID: Q9UNE7...
Biology Products: